Intelligent Bio SolutionsINBS +0.44%46 Days Payable is 684.98 as of Mar. 2026, which is 252% above its 10-year median of 194.62. GuruFocus rates INBS with a GF Score™ of 46/100 and a GF Value™ of $3.93 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Intelligent Bio Solutions ranks better than 92.2% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Intelligent Bio Solutions's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligent Bio Solutions Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Days Payable distribution charts can be found below:
* The bar in red indicates where Intelligent Bio Solutions's Days Payable falls into.
Intelligent Bio Solutions Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Intelligent Bio Solutions's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions (INBS) has a Days Payable of 684.98 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Intelligent Bio Solutions and its competitors. This is 252% above median its historical median of 194.62. Over the past decade, Intelligent Bio Solutions' Days Payable has ranged from 151.48 to 499.05. According to the industry distribution chart, Intelligent Bio Solutions ranks #62 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 7.8%.
Is Intelligent Bio Solutions' Days Payable too high?
Intelligent Bio Solutions' current Days Payable of 684.98 is 252% above median its 10-year median of 194.62. Over the past 10 years, this metric has ranged from a low of 151.48 to a high of 499.05. The Medical Devices & Instruments industry median Days Payable is 68.07. Intelligent Bio Solutions' value of 684.98 is 906.3% above this industry median. Based on the distribution chart, Intelligent Bio Solutions ranks #62 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Days Payable compare to ITOC and WOK?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #62 out of 795 companies for Days Payable. This places Intelligent Bio Solutions in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Intelligent Bio Solutions' value of 684.98 is 906.3% above this benchmark. Historically, Intelligent Bio Solutions' own Days Payable has ranged from 151.48 to 499.05 over the past decade. While the company's 10-year median is 194.62 vs. the industry median of 68.07, Intelligent Bio Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Intelligent Bio Solutions's current Days Payable of 684.98 is 906.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Intelligent Bio Solutions and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intelligent Bio Solutions's current Days Payable is 684.98, which is 252% above median its own 10-year median of 194.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Possible Value Trap. The stock's GF Value™ is $3.93, compared to a current price of $2.26 — trading 42.5% below its estimated fair value. The current Days Payable is 684.98, which is 252% above median its 10-year median of 194.62 and 906.3% above the Medical Devices & Instruments industry median of 68.07. Intelligent Bio Solutions' overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Days Payable is 684.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intelligent Bio Solutions (INBS) Overvalued in 2026?
Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued.
The current stock price of $2.26 is trading 42.5% below its estimated GF Value™ of $3.93.
GuruFocus considers Intelligent Bio Solutions to be Possible Value Trap.
Key valuation signals for INBS:
Days Payable: 684.98 (252% above median its 10-year median of 194.62)
GF Value™: $3.93 vs. price of $2.26 (42.5% below fair value)
Industry Position: 906.3% above the Medical Devices & Instruments median (#62 of 795)
No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
46GF Score
Get the complete analysis for INBS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INBS has been successfully added to your 
